Back

Cardiac magnetic resonance imaging in Fabry cardiomyopathy

26 August 2018 (17:25 - 17:35)
Organised by:
Congress Presentation Part of: Cardiomyopathy in Fabry disease Clinical, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Sergey Moiseev

I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)

5 More presentations in this session

Presentation thumbnail
Hypertrophy of unaffected cardiomyocytes concurs to severity of cardiomyopathy in female patients with Fabry disease
Associate Professor C. Chimenti (Rome, IT)
Abstract
Presentation thumbnail
Plasma lysoGb3 useful as biomarker in screening for Fabry disease in patients with mild left ventricular hypertrophy
Doctor M. Kagimoto (Yokohama, JP)
Abstract Slides Video
Presentation thumbnail
Speckle-tracking analysis of right ventricular function in Fabry disease - is left ventricle the only diseased chamber ?
Doctor J. Liao (Taipei, TW)
Abstract
Presentation thumbnail
Treatment of cardiac manifestations in Fabry disease with the oral drug Migalastat: First 12 months results from a cohort of amenable all-comers
Mr J. Muentze (Wuerzburg, DE)
Abstract
Presentation thumbnail
Novel electrocardiographic parameters for the detection of Fabry Disease - A comparative multi-centre study
Doctor M. Namdar (Geneva, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiomyopathy in Fabry disease

The Event

Event poster

ESC Congress 2018

26 August 2018 17:25 CET
You may be interested in
thumbnail
Congress Presentation
Myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging with contrast-enhancement in patients with Fabry disease.
6 May 2021
thumbnail
Congress Session
Clinical course of specific cardiomyopathies
18 May 2025
thumbnail
Congress Presentation
Finding the gaps in managing Fabry disease in women: the Romanian experience
27 August 2022
thumbnail
Congress Presentation
Cardiac magnetic resonance imaging in differential diagnosis of cardiac masses
11 December 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources